Trials / Recruiting
RecruitingNCT03083197
Scrub Typhus Antibiotic Resistance Trial
The Scrub Typhus Antibiotic Resistance Trial (START) Comparing Doxycycline and Azithromycin Treatment Modalities in Areas of Reported Antimicrobial Resistance for Scrub Typhus
- Status
- Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 177 (estimated)
- Sponsor
- University of Oxford · Academic / Other
- Sex
- All
- Age
- 15 Years
- Healthy volunteers
- Not accepted
Summary
Study type: Randomized Control Treatment Trial Study population: Male and female patients with ≥15 years of age and acute scrub typhus Duration: 2 years Study Design: Prospective, open-label, randomized-controlled treatment trial in patients ≥15 years old admitted to hospital with acute scrub typhus. Randomization into 3 oral treatment arms (each n=59 patients, total n=177): i) 7 days of doxycycline, ii) 3 days of doxycycline, and iii) 3 days of azithromycin Primary Objective: To evaluate the clinical and microbiological responses in scrub typhus patients to three oral treatment regimens: 7 days of doxycycline, 3 days of doxycycline, and 3 days of azithromycin Secondary Objectives: 1. To perform pharmacokinetic/pharmacodynamics (PK/PD) characterization of the therapeutic responses for doxycycline and azithromycin, incl. serial bacterial load measurements. 2. To define clinical, bacterial, pathophysiological and pharmacological factors associated with disease severity, fever-clearance times (FCT), treatment failures and relapse/re-infection. 3. To determine the minimum inhibitory concentrations (MIC) of clinical Orientia tsutsugamushi isolates to doxycycline, azithromycin and chloramphenicol, using in vitro growth-inhibition assays 4. To genotype all clinical isolates using whole genome sequencing for comparative genomics. 5. To dissect the natural immune response in scrub typhus, using antigen-specific cellular immune and antibody studies, and cytokine profiling
Detailed description
The funder is USAMRMC - MIDRP and Grant No. DHP-Award D6.7\_15\_C2\_I\_15\_J9\_1317
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Doxycycline 7 days | loading dose 200mg PO, then 100mg PO every 12 hours for 7 days |
| DRUG | Doxycycline 3 days | loading dose 200mg PO, then 100mg PO every 12 hours for 3 days |
| DRUG | Azithromycin 3 days | loading dose 1000mg PO on day 1, then 500mg PO every 24 hours on days 2 and 3 |
Timeline
- Start date
- 2017-10-15
- Primary completion
- 2026-10-01
- Completion
- 2026-10-01
- First posted
- 2017-03-17
- Last updated
- 2026-01-12
Locations
2 sites across 1 country: Thailand
Source: ClinicalTrials.gov record NCT03083197. Inclusion in this directory is not an endorsement.